Zio by iRhythm

Clinical trial: Zio by iRhythm significantly improves health outcomes for at-risk patients

Data published in PLOS One shows continuous monitoring leads to earlier diagnosis and prevents adverse cardiac events, furthering the case for cardiac screening.

iRhythm, Verily to develop health management solutions for Atrial Fibrillation patients

The two companies aim to collaborate on solutions providing early warnings, enabling the identification of patients that could otherwise go undiagnosed.
myZIO app

iRhythm’s new iOS app enables patients to report irregular heartbeat symptoms

The application also provides reminders and education, answering common questions and offering recommendations on the use of the ZIO Patch.
iRhythm ZIO Service

iRhythm secures $17 million in Series E funding to further grow its ZIO Service

The new cash will be used to further grow iRhythm's ZIO Service, which has been used with almost 250,000 patients at over 800 institutions across the U.S.